Glenmede Trust’s Frontline FRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-1
Closed 2518
2016
Q3
$0 Sell
1
-31
-97% -$240 ﹤0.01% 2613
2016
Q2
$0 Hold
32
﹤0.01% 2589
2016
Q1
$0 Hold
32
﹤0.01% 2650
2015
Q4
$0 Hold
32
﹤0.01% 2689
2015
Q3
$0 Hold
32
﹤0.01% 2753
2015
Q2
$0 Hold
32
﹤0.01% 2712
2015
Q1
$0 Sell
32
-13,782
-100% -$192K ﹤0.01% 2483
2014
Q4
$173K Buy
13,814
+13,424
+3,442% +$109K ﹤0.01% 1360
2014
Q3
$2K Buy
+390
New +$4.27K ﹤0.01% 2348
2014
Q2
Sell
-162
Closed -$3K 2354
2014
Q1
$3K Sell
162
-2,086
-93% -$43.3K ﹤0.01% 2229
2013
Q4
$42K Buy
2,248
+2,229
+11,732% +$30.6K ﹤0.01% 1664
2013
Q3
$0 Buy
+19
New +$238 ﹤0.01% 2227

Other funds holding FRO

Glenmede Trust's FRO Position: Q4 2016 in Review

Glenmede Trust sold out of Frontline (FRO) in Q4 2016, closing a stake of 1 share.

Glenmede Trust first reported a position in FRO in Q3 2013 and held it in 12 quarters. The position peaked at $173K in Q4 2014. 101 funds tracked by Wall St. Rank hold FRO as of Q4 2016.

  • Glenmede Trust reported no remaining Frontline position as of Q4 2016 after selling out during the quarter.
  • Glenmede Trust sold 1 Frontline share in Q4 2016.
  • Glenmede Trust first reported a position in Frontline in Q3 2013 and held it in 12 quarters.
  • Glenmede Trust's Frontline position peaked at $173K in Q4 2014.
  • 101 funds tracked by Wall St. Rank held Frontline as of Q4 2016.

Based on Glenmede Trust's 13F filing for Q4 2016, filed 14 Feb 2017.